Enamine is a scientifically driven company established in 1991, in Ukraine. Today we have 32 years of experience in chemistry and biology research and development.
There are over 700 professional chemists and more than 100 biologistsin Enamine,and Enamine is 100% service oriented and no own drug research ,we have locations in Europe (Ukraine, Latvia, Poland, Germany), and United States,we have integrated projects from pilot screening till formulation studies.
Founded by the multidisciplinary team of scientists and engineers of Peking University in 2016, Beijing Transcend Vivoscope Bio-Technology Co., Ltd.(TVS) has grown into one of the most innovative companies in China. With its cutting-edge miniature multi-photon microscopy technology, TVS is committed to providing the most advanced imaging products and solutions to empower biomedical researches worldwide.
Hangzhou Shengke Instrument Co., Ltd. is a company specialized in biomedical related instruments and reagents. The company specializes in sales agents of famous brands at home and abroad. In recent years, with good service and management, the market share of agent brands has been increasing, and the scale of the company has been expanding.
Hangzhou Baiou Biotechnology Co.,Ltd. was founded in 2015. As a supplier of laboratory and biopharma equipment, and medical devices, we offer tailored solutions that fit the needs of laboratories in various industries.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s FSP platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora™ CS; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
NovelBio was established in 2010 and was awarded as a specialized and sophisticated enterprise in 2022. It has been continuously rated as a National High-tech Enterprise since 2016. We are committed to the research and development of cutting-edge single-cell and spatial transcriptome multi-omics products and providing high-quality services from tissue processing to data analysis.
Sony Life Sciences can be traced back to iCyt Mission, established in 1995 at the Innovation and Development Center of Illinois State University in the United States. In 2010, iCyt was fully acquired by Sony Group as an independent subsidiary, marking a milestone for Sony Group's strong investment in the field of life sciences and the application of its technological advantages in optics and electronics to support life science research, achieving another innovative development.
Over the years, Sony Life Sciences flow cytometry products have received numerous outstanding new product awards as well as technology awards including the Frost & Sullivan Emerging Technology award, and the Milestone Award.
Shenzhen Huixin Life Technologies Co., Ltd.
Shenzhen Huixin Life Technologies Co., Ltd. (referred to as Huixin Lifetech) is a global leader in exosome isolation and purification equipment, established in 2017. Co-founded by renowned scientists and industry experts in the field of exosomes, Huixin Lifetech focuses on providing upstream core tools for exosome research, utilizing breakthrough dual-membrane isolation technology. The company is dedicated to addressing the challenges of automated, standardized, and large-scale exosome preparation, thereby advancing the industrial application of exosomes in diagnostics, therapuetics, drug delivery, and regenerative medicine.
One of its flagship products, EXODUS, is the world's leading fully automated exosome isolation and purification system. This innovative membrane isolation system is based on ultrasonic nanofiltration technology, distinguishing it from traditional tangential flow filtration and size exclusion chromatography methods. Since its mass production and commercialization at the end of 2021, EXODUS has served over 500 customers and gained recognition from top universities, research institutions, and pharmaceutical companies worldwide, including the National Institute for Environmental Health, Harvard Medical School, MD Anderson Cancer Center, and Capricor in the United States.
